Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning

The outcomes of adult acute lymphoblastic leukemia (ALL) patients with chemotherapy or autologous hematopoietic stem cell transplantation (HSCT) are unsatisfactory. Therefore, allogeneic (allo) HSCT has been applied to those patients in first complete remission (CR1), and has shown a long-term survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Masahiro, Shigematsu, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552453/
https://www.ncbi.nlm.nih.gov/pubmed/26322249
http://dx.doi.org/10.1186/s40164-015-0015-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552453/
https://www.ncbi.nlm.nih.gov/pubmed/26322249
http://dx.doi.org/10.1186/s40164-015-0015-0

Ejemplares similares